<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-455
Date of Submission: 2025-05-11

This report was submitted by a Nurse from Sanders, Castro and Miller Medical Center concerning patient ANON-PX-5141. The subject is a 40-year-old male with a significant medical history including seasonal allergies, hypertension, osteoarthritis, atrial fibrillation. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin (Penicillin antibiotic) administered via the Intravenous route at a dosage of 141mg, initiated on 2025-02-22 for Bacterial infection with the course ongoing; Gabapentin (Anticonvulsant) administered via the Oral route at a dosage of 147mg, initiated on 2025-02-22 for Neuropathic pain with the course ongoing.

On approximately 2025-03-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Dizziness, Vomiting. The Dizziness was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. The Vomiting was classified as Severe in severity. This necessitated clinical intervention. The documented action was: Prescribed beyond and advised time. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 6 was calculated, The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Negative dechallenge'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Agreement Mrs fast best truth fear. Out continue clear. Current unit sure also watch everything.</data>
report_id: ADR-2025-455
report_date: '2025-05-11'
patient_details:
  patient_id: ANON-PX-5141
  gender: Male
  relevant_history:
  - seasonal allergies
  - hypertension
  - osteoarthritis
  - atrial fibrillation
  age_at_reaction: 40
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 141mg
  route_of_administration: Intravenous
  start_date: '2025-02-22'
  indication_for_use: Bacterial infection
  drug_class: Penicillin antibiotic
- drug_name: Gabapentin
  dosage: 147mg
  route_of_administration: Oral
  start_date: '2025-02-22'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
adverse_reactions:
- symptom_name: Dizziness
  onset_date: '2025-03-18'
  severity: Mild
  outcome: Recovering
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2025-03-18'
  severity: Severe
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed beyond and advised time.
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Negative dechallenge
  naranjo_score: 6
reporting_facility: Sanders, Castro and Miller Medical Center
reporter_type: Nurse
notes: Agreement Mrs fast best truth fear. Out continue clear. Current unit sure also
  watch everything.
